CareCloud stock extends 2026 losses as investors wait for next earnings

CareCloud stock trades below its start-of-year level as investors look past recent volatility toward the company’s next expected earnings date in November 2026.

CareCloud, Inc. (ISIN US14169G1058), formerly known by the ticker MTBC, is trading in 2026 below its opening share price for the year, signaling a cautious stance among investors ahead of the next expected earnings release in November 2026.

CareCloud stock performance in 2026

Recent market data compiled on August 28, 2026 shows CareCloud stock quoted at $2.49 with a single day decline of 6.39%, highlighting how sensitive the shares remain to changing sentiment in the healthcare technology space. CareCloud’s market capitalization at that point stood at $105.81 million, giving the company a small-cap profile in the Nasdaq healthcare technology universe and underscoring that relatively modest trading flows can translate into noticeable percentage moves. The same overview notes that CareCloud stock started 2026 at $2.92 and has since fallen 13.7% to around $2.52, placing the current level well below the year’s opening price and providing a concrete benchmark for investors tracking year-to-date performance.

A separate stock analysis page updated on August 28, 2026 lists a last traded price of $2.46 at 1:33 p.m. Eastern Time and reports the price to earnings ratio at 36.00, lower than a cited broader market average P/E of 39.50. That comparison suggests that on an earnings multiple basis CareCloud trades at a discount to the overall market even though its absolute valuation still embeds expectations of profit growth. The same analysis indicates that CareCloud stock has decreased from $2.92 at the start of the year to $2.52, confirming the double-digit percentage decline in 2026 that investors must weigh against earnings growth expectations.

Latest earnings and growth expectations

The stock analysis materials also provide a snapshot of consensus expectations for CareCloud’s profitability. Earnings for CareCloud are expected to grow by 16.22% over the coming year, with diluted earnings per share projected to increase from $0.37 to $0.43. That forecasted expansion in EPS, if realized, would help support the current P/E ratio and could gradually bring the earnings multiple closer to the broader market level if the share price does not move in lockstep with profit growth.

In the same data set, the company calendar section lists its last earnings date as August 6, 2026, placing that report well inside the standard nine-month freshness window for quarterly figures. The calendar also identifies November 5, 2026 as the next estimated earnings date with a fiscal year end of December 31, 2026. For investors, the timeline from the early August 2026 release to the early November 2026 update frames a period in which the current valuation, including the 36.00 P/E ratio and the more than 13% year-to-date share price decline, must be assessed in light of projected EPS growth from $0.37 to $0.43 and any operational changes that emerge in the next report.

Valuation context versus the broader market

The relationship between CareCloud’s P/E ratio and a reported broader market P/E of 39.50 offers a useful valuation anchor. At 36.00, CareCloud trades at a lower earnings multiple than the wider market, yet the forecast EPS growth rate of 16.22% points to a business that investors expect to expand earnings faster than many large index constituents. The fact that the stock has declined from $2.92 at the start of 2026 to levels around $2.46 to $2.52 by late August 2026 means that multiple compression has accompanied share price weakness, a combination that can appeal to investors who prioritize growth at a justified price.

However, the small-cap nature of CareCloud, reflected in the market cap of $105.81 million as of August 28, 2026, also implies higher volatility and a greater sensitivity to quarterly performance than is typical for large diversified healthcare technology names. With the next earnings date estimated for November 5, 2026, the span between now and that release gives market participants time to reassess whether a projected increase in EPS from $0.37 to $0.43 aligns with actual operational progress and whether the current share price, down 13.7% since the start of the year, fully discounts any execution risks.

Business model and representative product

CareCloud’s core business centers on technology platforms that help medical practices and healthcare providers manage clinical, financial, and administrative workflows more efficiently. The company’s solutions typically include electronic health records, practice management tools, revenue cycle management, and patient engagement systems designed to streamline billing and scheduling. A representative product offering is its cloud-based practice management and revenue cycle service, which integrates appointment scheduling, insurance verification, claim submission, and payment posting into a unified dashboard, allowing staff to monitor key metrics such as claim acceptance rates and days in accounts receivable in real time. By focusing on software-driven automation, CareCloud aims to reduce manual tasks and errors for clients, which can improve cash flow and lower administrative costs for small and midsize medical practices.

CareCloud stock and investor takeaway

As of late August 2026, CareCloud stock trades on Nasdaq under the current symbol CCLD in U.S. dollars, with recent quotes showing prices in the mid-$2 range and a market capitalization just above $100 million. The combination of a 13.7% year-to-date share price decline from $2.92 to around $2.52, a P/E ratio of 36.00 compared with a broader market multiple of 39.50, and an expected 16.22% rise in EPS from $0.37 to $0.43 over the coming year illustrates the balanced picture investors must consider ahead of the estimated November 5, 2026 earnings release.

Fact box

Company: CareCloud, Inc.

ISIN: US14169G1058

Ticker: CCLD

Exchange: Nasdaq

Price (as of August 28, 2026, 4:08 p.m. ET): $2.49 USD

Market cap: $105.81 million (as of August 28, 2026)

Sector / Industry: Healthcare / Healthcare technology

Index membership: Nasdaq Composite

Next earnings date: November 5, 2026